The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

Abstract: The most commonly diagnosed cancers in the world are Lung cancer. Beforehand prediction, detection and diagnosis of lung cancer has become essential. This paper draws light to the lung ...

Long before the UFC became a powerhouse, rivalries like the one that concluded on this day in 2006 helped it gather momentum. The fight between Forrest Griffin and Stephan Bonnar is often regarded as ...

Daniel Cormier is rushing to the defense of Magomed Ankalaev after fans were skeptical of the injury claims made after the fighter’s championship loss at UFC 320 against Alex Pereira. Ankalaev’s reign ...

Abstract: An increased mortality rate is related to lung cancer. It is amongst the primary category of cancer. Lung cancer is a tumor that develops in the lung tissues, specifically in the linings of ...

The Columbia University Armenian Center will host Peter Balakian for a reading and discussion on Monday, October 27, 2025, at 4 p.m., at Faculty House (Entrance on 116th St. between Amsterdam and ...

Amazon announced it is rolling out "pharmacy kiosks" beginning in December. The self-service kiosks will allow Amazon's One Medical patients to bypass brick-and-mortar pharmacies and get their ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...

The S&P 500 fell for the first time in more than a week as Wall Street pumped the brakes on the autumn AI frenzy. The market benchmark dropped 0.4%. The Dow Jones Industrial Average fell 92 points, or ...

Shares in small Canadian mining firm Trilogy Metals skyrocketed nearly 215% Tuesday after the US government said it would take a 10% stake in it. The partnership includes a $35.6 million investment in ...